Literature DB >> 2407306

Immunogenetic and cellular immune mechanisms in rheumatoid arthritis: relevance to new therapeutic strategies.

G Kingsley1, C Pitzalis, G S Panayi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2407306     DOI: 10.1093/rheumatology/29.1.58

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


× No keyword cloud information.
  11 in total

Review 1.  Immunotherapy of rheumatoid arthritis.

Authors:  R A Watts; J D Isaacs
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

2.  Perforin and granzyme A expression identifying cytolytic lymphocytes in rheumatoid arthritis.

Authors:  G M Griffiths; S Alpert; E Lambert; J McGuire; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

3.  Expression of cytolytic mediators by synovial fluid lymphocytes in rheumatoid arthritis.

Authors:  L H Young; S V Joag; P Y Lin; S F Luo; L M Zheng; C C Liu; J D Young
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

Review 4.  Anti-integrin immunotherapy in rheumatoid arthritis: protective effect of anti-alpha 4 antibody in adjuvant arthritis.

Authors:  C Barbadillo; A G-Arroyo; C Salas; J Mulero; F Sánchez-Madrid; J L Andreu
Journal:  Springer Semin Immunopathol       Date:  1995

5.  The effect of auranofin and sulphasalazine therapy on circulating levels of interleukin 6 in rheumatoid arthritis patients.

Authors:  A Crilly; H A Capell; J Watson; R Madhok
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

Review 6.  Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?

Authors:  S Gay; R E Gay; W J Koopman
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

7.  Kinetics of cytokine secretion by mononuclear cells of the blood from rheumatoid arthritis patients are different from those of healthy controls.

Authors:  S Ruschen; W Stellberg; H Warnatz
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

8.  Lymphocyte responses to DR1/4 restricted peptides in rheumatoid arthritis.

Authors:  M A Skinner; L Watson; A Geursen; P L Tan
Journal:  Ann Rheum Dis       Date:  1994-03       Impact factor: 19.103

9.  Treatment of rheumatoid arthritis with anti CD4 monoclonal antibody. Open study of 25 patients with the B-F5 clone.

Authors:  D Wendling; E Racadot; B Morel-Fourrier; J Wijdenes
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

10.  Photodynamic therapy; a comparison with other immunomodulatory treatments of adjuvant-enhanced arthritis in MRL-lpr mice.

Authors:  L G Ratkay; R K Chowdhary; H C Neyndorff; J Tonzetich; J D Waterfield; J G Levy
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.